Device Trial Radar · NCT03611907
Comparing Two Types of Needle for Oocytes Retrieval
Last checked: Nov 19, 2026Latest source record: Sep 27, 2022 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
200
Actual
Start
Mar 6, 2019
Primary completion
May 31, 2020
Study completion Jan 20, 2021
Sponsor
- Lead sponsor
- Istituto Clinico HumanitasAcademic, hospital or other
- Sponsor type
- Academic, hospital or other
- First posted
- Aug 2, 2018
Design
- Study type
- Interventional
- Phase
- Not applicable (typical for device studies)
- Allocation
- Randomized
- Model
- Parallel
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated device
- No
- Who can join
- Female only, from 18 years, up to 42 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
In the early stages of assisted reproductive technologies (ART), oocyte retrieval was performed via laparoscopy, a cumbersome and expensive process requiring general anesthesia. Today, transvaginal oocyte retrieval for ART is a routine procedure performed under ultrasound guidance. Double-lumen retrieval needles, which are capable of flushing ovarian follicles, were developed to overcome the possibility of oocyte retention within the ovarian follicles and retrieval collection system. Single lumen needles have been introduced and are routinely used by most groups due to their supposed ability to retrieve the same number of oocytes in a shorter operation time.
Conditions
- Infertility, Female
- ART
Interventions
Oocyte retrieval with only aspiration system "SL1(Cook® Single Lumen)"Device
In this intervention a 17-Gauge needle is used to aspirate the follicles
Oocyte retrieval with aspiration and flushing system "DL1 (Cook® EchoTip® Double Lumen)"Device
In this intervention a 17-Gauge needle is used to aspirate follicle, and consequently a 1 mL flush is injected and aspirated twice for each punctured follicle
Primary outcomes
What the sponsor says the trial is designed to measure.
- Number of retrieved oocytes per procedureTime frame: through study completion, 9 months
Locations
1 site in 1 country. Site status is shown where the registry gives one.
Paolo Emanuele Levi Setti
Rozzano, MI, Italy
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.